Newsroom | 72154 results

Sorted by: Latest

Science
-

Nomic joins the HESI Global OASIS Consortium to Advance Human-Relevant Safety Assessment Through Proteomics

MONTREAL--(BUSINESS WIRE)--Nomic Bio Inc., today announced they will partner with the Health and Environmental Sciences Institute’s (HESI Global) Omics for Assessing Signatures for Integrated Safety (OASIS) Consortium to identify biomarker signatures for liver toxicity using large-scale protein profiling of human liver-derived cell models. The OASIS Consortium is designed to support more predictive, efficient, and human-relevant approaches to compound safety assessment, consistent with the grow...
-

Molecular Instruments Advances Automated Multiplex Tissue Research with HCR™ Gold IF on the BOND RX Research Staining Instrument

LOS ANGELES--(BUSINESS WIRE)--Leveraging trusted automation from Leica Biosystems, HCR™ Gold IF helps researchers move from tissue to insight faster with flexible, higher-plex IF....
-

Agragene Selected for USDA Grand Challenge and FFAR Grants to Combat New World Screwworm

ST. LOUIS--(BUSINESS WIRE)--Agragene announces funding from the USDA New World Screwworm Grand Challenge and from the Foundation for Food & Agriculture Research. The grants were awarded through competitive processes by both USDA and FFAR with the former involving hundreds of submissions. Both grants are designed to facilitate additional research on the company’s novel insect sterility technology.Agragene uses precision-guided sterile insect technique (pgSIT) to deliver healthy, sterile male...
-

ReliaQuest Invests $1.5 Million to Advance AI and Cybersecurity Education at the University of South Florida

TAMPA, Fla.--(BUSINESS WIRE)--ReliaQuest today announced a $1.5 million investment to expand AI cybersecurity research and education at the University of South Florida’s College of Artificial Intelligence, Cybersecurity and Computing. The gift will establish the college’s first-ever endowed professorship and create a new study track within the ReliaQuest Labs program focused on artificial intelligence-supported software engineering. “Cybersecurity is the greatest technical challenge of our gene...
-

Constructive Bio Founder and Chief Scientific Officer, Professor Jason Chin, Named the 2026 Heinrich Wieland Prize Recipient

CAMBRIDGE, England--(BUSINESS WIRE)--Constructive Bio’s founder and Chief Scientific Officer, Professor Jason Chin, has been named the recipient of the 2026 Heinrich Wieland Prize, one of Europe’s most prestigious honours for fundamental research in the life sciences. The award places Professor Chin among past laureates, including five Nobel Prize winners, and recognises the genetic-code-expansion technology now being applied to next-generation therapeutics, including GLP-1s. The award, present...
-

Quantori MLConfGen Wins “Machine Learning Innovation Award” in 2026 AI Breakthrough Awards Program

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quantori's MLConfGen wins the Machine Learning Innovation Award at the 2026 AI Breakthrough Awards for advancing AI-assisted molecular design....
-

Clinilabs Announces New Affiliation With Rutgers University

EATONTOWN, N.J.--(BUSINESS WIRE)--Clinilabs (“Clinilabs LLC”), a global full‑service CRO specializing in CNS drug and device development, announced a new partnership with Rutgers Health, School of Health Professions, Master of Science, Clinical Research Management program (MS CRM), reflecting the company’s ongoing commitment to advancing scientific education and strengthening the future clinical research workforce. As one of the nation’s leading public research institutions, Rutgers brings exce...
-

Immunis Unveils New Brand Identity, Reinforcing Mission to Advance Multi-active Biologics for Muscle Health and Healthy Aging

IRVINE, Calif.--(BUSINESS WIRE)--Immunis, a clinical-stage biotech company developing a first-in-class multi-active biologic, announced the launch of its new logo and brand identity. The rebrand reflects the company’s scientific focus on multi-pathway biology and its mission to improve muscle function, metabolic health, and overall healthspan. Immunis’ platform is built on the understanding that age-related and chronic diseases are driven by interconnected biological pathways. Unlike convention...
-

Komodo Expands Strategic Partnership With Alnylam to Scale AI-Powered Intelligence Platform

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health®, the leader in AI-powered healthcare intelligence, today announced an expanded strategic partnership with Alnylam Pharmaceuticals (Nasdaq: ALNY), the leading RNAi therapeutics company to scale Marmot™, Komodo’s analytics AI platform, across key enterprise functions at Alnylam. Built on the Healthcare Map®, the industry’s most comprehensive view of more than 330 million de-identified patient journeys, Marmot helps organizations move beyon...
-

Asahi Kasei’s Novel Forward Osmosis–Membrane Distillation System Installed at Peptistar's API Manufacturing Facility for Reduced Pharmaceutical Manufacturing Time

TOKYO--(BUSINESS WIRE)--Peptistar has integrated Asahi Kasei’s novel forward osmosis–membrane distillation (FO–MD) system into its facility for trial production of APIs....